Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

FIG vs ADBE vs CXM vs CNVS vs DSGN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FIG
Figma, Inc.

Software - Application

TechnologyNYSE • US
Market Cap$6.52B
5Y Perf.-30.1%
ADBE
Adobe Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$99.46B
5Y Perf.-58.9%
CXM
Sprinklr, Inc.

Software - Application

TechnologyNYSE • US
Market Cap$1.24B
5Y Perf.-75.4%
CNVS
Cineverse Corp.

Entertainment

Communication ServicesNASDAQ • US
Market Cap$50M
5Y Perf.-90.0%
DSGN
Design Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$986M
5Y Perf.-20.6%

FIG vs ADBE vs CXM vs CNVS vs DSGN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FIG logoFIG
ADBE logoADBE
CXM logoCXM
CNVS logoCNVS
DSGN logoDSGN
IndustrySoftware - ApplicationSoftware - InfrastructureSoftware - ApplicationEntertainmentBiotechnology
Market Cap$6.52B$99.46B$1.24B$50M$986M
Revenue (TTM)$1.06B$24.45B$857M$55M$0.00
Net Income (TTM)$-1.31B$7.21B$23M$-9M$-70M
Gross Margin82.4%89.2%67.4%53.9%
Operating Margin-122.2%36.8%4.7%-12.5%
Forward P/E81.1x10.2x11.2x16.1x
Total Debt$58M$6.65B$47M$462K$645K
Cash & Equiv.$403M$5.43B$163M$14M$17M

FIG vs ADBE vs CXM vs CNVS vs DSGNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FIG
ADBE
CXM
CNVS
DSGN
StockJun 21May 26Return
Adobe Inc. (ADBE)10041.1-58.9%
Sprinklr, Inc. (CXM)10024.6-75.4%
Cineverse Corp. (CNVS)10010.0-90.0%
Design Therapeutics… (DSGN)10079.4-20.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: FIG vs ADBE vs CXM vs CNVS vs DSGN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ADBE leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Cineverse Corp. is the stronger pick specifically for growth and revenue expansion. DSGN also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
FIG
Figma, Inc.
The Growth Angle

FIG lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
ADBE
Adobe Inc.
The Long-Run Compounder

ADBE carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 151.0% 10Y total return vs DSGN's -61.9%
  • Better valuation composite
  • 29.5% margin vs FIG's -124.5%
  • Beta 0.70 vs FIG's 1.55
Best for: long-term compounding
CXM
Sprinklr, Inc.
The Income Pick

CXM is the clearest fit if your priority is income & stability and defensive.

  • Dividend streak 1 yrs, beta 0.74
  • Beta 0.74, current ratio 1.60x
Best for: income & stability and defensive
CNVS
Cineverse Corp.
The Growth Play

CNVS is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 59.1%, EPS growth 109.0%, 3Y rev CAGR 11.7%
  • 59.1% revenue growth vs DSGN's -24.6%
Best for: growth exposure
DSGN
Design Therapeutics, Inc.
The Defensive Pick

DSGN ranks third and is worth considering specifically for sleep-well-at-night.

  • Lower volatility, beta 1.49, Low D/E 0.3%, current ratio 17.14x
  • +336.2% vs FIG's -83.3%
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthCNVS logoCNVS59.1% revenue growth vs DSGN's -24.6%
ValueADBE logoADBEBetter valuation composite
Quality / MarginsADBE logoADBE29.5% margin vs FIG's -124.5%
Stability / SafetyADBE logoADBEBeta 0.70 vs FIG's 1.55
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)DSGN logoDSGN+336.2% vs FIG's -83.3%
Efficiency (ROA)ADBE logoADBE24.8% ROA vs FIG's -56.0%, ROIC 51.4% vs -95.3%

FIG vs ADBE vs CXM vs CNVS vs DSGN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FIGFigma, Inc.

Segment breakdown not available.

ADBEAdobe Inc.
FY 2025
Digital Media
74.3%$17.6B
Digital Experience
24.7%$5.9B
Print And Publishing
1.1%$256M
CXMSprinklr, Inc.
FY 2025
License and Service
90.1%$718M
Professional Services
9.9%$78M
CNVSCineverse Corp.

Segment breakdown not available.

DSGNDesign Therapeutics, Inc.

Segment breakdown not available.

FIG vs ADBE vs CXM vs CNVS vs DSGN — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLADBELAGGINGFIG

Income & Cash Flow (Last 12 Months)

ADBE leads this category, winning 6 of 6 comparable metrics.

ADBE and DSGN operate at a comparable scale, with $24.5B and $0 in trailing revenue. ADBE is the more profitable business, keeping 29.5% of every revenue dollar as net income compared to FIG's -124.5%. On growth, ADBE holds the edge at +12.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
RevenueTrailing 12 months$1.1B$24.5B$857M$55M$0
EBITDAEarnings before interest/tax-$1.3B$9.6B$48M-$2M-$78M
Net IncomeAfter-tax profit-$1.3B$7.2B$23M-$9M-$70M
Free Cash FlowCash after capex$243M$10.3B$155M-$13M-$54M
Gross MarginGross profit ÷ Revenue+82.4%+89.2%+67.4%+53.9%
Operating MarginEBIT ÷ Revenue-122.2%+36.8%+4.7%-12.5%
Net MarginNet income ÷ Revenue-124.5%+29.5%+2.7%-16.7%
FCF MarginFCF ÷ Revenue+23.1%+42.2%+18.1%-22.8%
Rev. Growth (YoY)Latest quarter vs prior year+12.0%+8.9%-60.0%
EPS Growth (YoY)Latest quarter vs prior year+11.4%-90.1%-113.2%+6.5%
ADBE leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

CNVS leads this category, winning 4 of 6 comparable metrics.

At 14.4x trailing earnings, ADBE trades at a 74% valuation discount to CXM's 56.2x P/E. On an enterprise value basis, CNVS's 3.1x EV/EBITDA is more attractive than CXM's 28.0x.

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
Market CapShares × price$6.5B$99.5B$1.2B$50M$986M
Enterprise ValueMkt cap + debt − cash$6.2B$100.7B$1.1B$37M$970M
Trailing P/EPrice ÷ TTM EPS-5.21x14.42x56.22x16.06x-12.94x
Forward P/EPrice ÷ next-FY EPS est.81.12x10.23x11.15x
PEG RatioP/E ÷ EPS growth rate1.59x
EV / EBITDAEnterprise value multiple10.57x28.02x3.14x
Price / SalesMarket cap ÷ Revenue6.17x4.18x1.45x0.64x
Price / BookPrice ÷ Book value/share4.31x8.85x2.20x1.21x4.26x
Price / FCFMarket cap ÷ FCF26.46x10.10x7.88x3.10x
CNVS leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

ADBE leads this category, winning 5 of 9 comparable metrics.

ADBE delivers a 62.3% return on equity — every $100 of shareholder capital generates $62 in annual profit, vs $-87 for FIG. DSGN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to ADBE's 0.57x. On the Piotroski fundamental quality scale (0–9), CNVS scores 7/9 vs DSGN's 2/9, reflecting strong financial health.

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
ROE (TTM)Return on equity-87.0%+62.3%+3.9%-24.4%-33.1%
ROA (TTM)Return on assets-56.0%+24.8%+2.0%-13.4%-31.3%
ROICReturn on invested capital-95.3%+51.4%+6.1%+20.3%-28.5%
ROCEReturn on capital employed-4.8%+44.6%+6.1%+22.3%-34.8%
Piotroski ScoreFundamental quality 0–936672
Debt / EquityFinancial leverage0.04x0.57x0.08x0.01x0.00x
Net DebtTotal debt minus cash-$345M$1.2B-$116M-$13M-$16M
Cash & Equiv.Liquid assets$403M$5.4B$163M$14M$17M
Total DebtShort + long-term debt$58M$6.6B$47M$462,000$645,000
Interest CoverageEBIT ÷ Interest expense66.23x-4.16x
ADBE leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DSGN leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in DSGN five years ago would be worth $6,517 today (with dividends reinvested), compared to $1,045 for CNVS. Over the past 12 months, DSGN leads with a +336.2% total return vs FIG's -83.3%. The 3-year compound annual growth rate (CAGR) favors DSGN at 33.5% vs FIG's -44.9% — a key indicator of consistent wealth creation.

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
YTD ReturnYear-to-date-48.6%-27.7%-30.9%+22.4%+73.5%
1-Year ReturnPast 12 months-83.3%-39.2%-39.8%-12.6%+336.2%
3-Year ReturnCumulative with dividends-83.3%-28.2%-56.0%-57.2%+137.8%
5-Year ReturnCumulative with dividends-83.3%-49.0%-71.3%-89.6%-34.8%
10-Year ReturnCumulative with dividends-83.3%+151.0%-71.3%-91.7%-61.9%
CAGR (3Y)Annualised 3-year return-44.9%-10.5%-23.9%-24.6%+33.5%
DSGN leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ADBE and DSGN each lead in 1 of 2 comparable metrics.

ADBE is the less volatile stock with a 0.70 beta — it tends to amplify market swings less than FIG's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DSGN currently trades 91.5% from its 52-week high vs FIG's 13.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
Beta (5Y)Sensitivity to S&P 5001.55x0.70x0.74x1.46x1.49x
52-Week HighHighest price in past year$142.92$422.95$9.40$7.39$17.25
52-Week LowLowest price in past year$16.60$224.18$4.71$1.77$3.11
% of 52W HighCurrent price vs 52-week peak+13.5%+56.9%+53.8%+34.8%+91.5%
RSI (14)Momentum oscillator 0–10051.148.345.153.566.3
Avg Volume (50D)Average daily shares traded14.1M5.4M3.5M140K399K
Evenly matched — ADBE and DSGN each lead in 1 of 2 comparable metrics.

Analyst Outlook

CXM leads this category, winning 1 of 1 comparable metric.

Analyst consensus: FIG as "Hold", ADBE as "Buy", CXM as "Hold", DSGN as "Buy". Consensus price targets imply 87.1% upside for FIG (target: $36) vs 10.8% for DSGN (target: $18).

MetricFIG logoFIGFigma, Inc.ADBE logoADBEAdobe Inc.CXM logoCXMSprinklr, Inc.CNVS logoCNVSCineverse Corp.DSGN logoDSGNDesign Therapeuti…
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuy
Price TargetConsensus 12-month target$36.17$345.50$7.13$17.50
# AnalystsCovering analysts762177
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+0.4%+11.3%+0.4%+0.4%0.0%
CXM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ADBE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CNVS leads in 1 (Valuation Metrics). 1 tied.

Best OverallAdobe Inc. (ADBE)Leads 2 of 6 categories
Loading custom metrics...

FIG vs ADBE vs CXM vs CNVS vs DSGN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FIG or ADBE or CXM or CNVS or DSGN a better buy right now?

For growth investors, Cineverse Corp.

(CNVS) is the stronger pick with 59. 1% revenue growth year-over-year, versus 7. 6% for Sprinklr, Inc. (CXM). Adobe Inc. (ADBE) offers the better valuation at 14. 4x trailing P/E (10. 2x forward), making it the more compelling value choice. Analysts rate Adobe Inc. (ADBE) a "Buy" — based on 62 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FIG or ADBE or CXM or CNVS or DSGN?

On trailing P/E, Adobe Inc.

(ADBE) is the cheapest at 14. 4x versus Sprinklr, Inc. at 56. 2x. On forward P/E, Adobe Inc. is actually cheaper at 10. 2x.

03

Which is the better long-term investment — FIG or ADBE or CXM or CNVS or DSGN?

Over the past 5 years, Design Therapeutics, Inc.

(DSGN) delivered a total return of -34. 8%, compared to -89. 6% for Cineverse Corp. (CNVS). Over 10 years, the gap is even starker: ADBE returned +151. 0% versus CNVS's -91. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FIG or ADBE or CXM or CNVS or DSGN?

By beta (market sensitivity over 5 years), Adobe Inc.

(ADBE) is the lower-risk stock at 0. 70β versus Figma, Inc. 's 1. 55β — meaning FIG is approximately 121% more volatile than ADBE relative to the S&P 500. On balance sheet safety, Design Therapeutics, Inc. (DSGN) carries a lower debt/equity ratio of 0% versus 57% for Adobe Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FIG or ADBE or CXM or CNVS or DSGN?

By revenue growth (latest reported year), Cineverse Corp.

(CNVS) is pulling ahead at 59. 1% versus 7. 6% for Sprinklr, Inc. (CXM). On earnings-per-share growth, the picture is similar: Cineverse Corp. grew EPS 109. 0% year-over-year, compared to -79. 5% for Sprinklr, Inc.. Over a 3-year CAGR, CNVS leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FIG or ADBE or CXM or CNVS or DSGN?

Adobe Inc.

(ADBE) is the more profitable company, earning 30. 0% net margin versus -118. 4% for Figma, Inc. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADBE leads at 36. 6% versus -122. 2% for FIG. At the gross margin level — before operating expenses — ADBE leads at 88. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FIG or ADBE or CXM or CNVS or DSGN more undervalued right now?

On forward earnings alone, Adobe Inc.

(ADBE) trades at 10. 2x forward P/E versus 81. 1x for Figma, Inc. — 70. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIG: 87. 1% to $36. 17.

08

Which pays a better dividend — FIG or ADBE or CXM or CNVS or DSGN?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is FIG or ADBE or CXM or CNVS or DSGN better for a retirement portfolio?

For long-horizon retirement investors, Adobe Inc.

(ADBE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 70), +151. 0% 10Y return). Figma, Inc. (FIG) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ADBE: +151. 0%, FIG: -83. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FIG and ADBE and CXM and CNVS and DSGN?

These companies operate in different sectors (FIG (Technology) and ADBE (Technology) and CXM (Technology) and CNVS (Communication Services) and DSGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FIG is a small-cap high-growth stock; ADBE is a mid-cap deep-value stock; CXM is a small-cap quality compounder stock; CNVS is a small-cap high-growth stock; DSGN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FIG

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Gross Margin > 49%
Run This Screen
Stocks Like

ADBE

Quality Mega-Cap Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

CXM

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 40%
Run This Screen
Stocks Like

CNVS

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 32%
Run This Screen
Stocks Like

DSGN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform FIG and ADBE and CXM and CNVS and DSGN on the metrics below

Revenue Growth>
%
(FIG: 41.0% · ADBE: 12.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.